The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview
Comparative Effectiveness Research · 2011
DOI: 10.2147/cer.s15861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Effectiveness Research, 2011. Verfasst von SK Mastan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mastan, S., Thirunagari, B. L., & Sathe (2011). The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview. Comparative Effectiveness Research. https://doi.org/10.2147/cer.s15861
Vancouver
Mastan S, Thirunagari BL, Sathe. The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview. Comparative Effectiveness Research. 2011. doi:10.2147/cer.s15861
BibTeX
@article{Mastan2011,
author = {Mastan, SK and Thirunagari, Bhavya Latha and Sathe},
title = {The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview},
journal = {Comparative Effectiveness Research},
year = {2011},
doi = {10.2147/cer.s15861}
}
EUVIMED